Denture stomatitis. The clinical effects of chlorhexidine and amphotericin B

Acta Odontol Scand. 1975;33(1):47-52. doi: 10.3109/00016357509004626.

Abstract

The clinical effects of an antibacterial substance with antifungal activity (chlorhexidine) and specific antimycotic (amphotericin B) in denture stomatitis were studied in 100 patients. Five 14-day regimens of chlorhexidine, amphotericin B or placebo lozenges combined with denture immersion in 0.2% chlorhexidine or water were tested. The efficiency of amphotericin B and chlorhexidine was comparable. This indicates that chlorhexidine has a considerable antifungal effect in the oral cavity and, further, that fungi are the responsible micro-organism in denture stomatitis rather than bacteria. Chlorhexidine frequently discloured the dentures. A high incidence of local and general predisposing factors to denture stomatitis, as well as of relapse 14 days after treatment, was observed.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Amphotericin B / therapeutic use*
  • Biguanides / therapeutic use*
  • Chlorhexidine / adverse effects
  • Chlorhexidine / therapeutic use*
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Erythema / complications
  • Humans
  • Maxillary Diseases / complications
  • Mycoses / drug therapy
  • Stomatitis / drug therapy*
  • Stomatitis, Denture / complications
  • Stomatitis, Denture / drug therapy*
  • Stomatitis, Denture / microbiology

Substances

  • Biguanides
  • Amphotericin B
  • Chlorhexidine